INGN 241 (Adenoviral-mda-7): Began Phase I trial

Introgen Therapeutics Inc. (INGN), Austin, Texas Product: INGN 241 (Adenoviral-mda-7) Business: Cancer, Gene/Cell therapy Therapeutic category: Gene therapy, Apoptosis Target: Tumor cells Description:...